- 1. Rao S.V., O’Donoghue M.L., Ruel M. et al. (2025) 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation, 151(13): e771–e862. doi: 10.1161/CIR.0000000000001309.
- 2. Byrne R.A., Rossello X., Coughlan J.J. et al. (2023) 2023 ESC Guidelines for the management of acute coronary syndromes. Eur. Heart J., 44(38): 3720–3826. doi: 10.1093/eurheartj/ehad191.
- 3. Ibanez B., James S., Agewall S. et al. (2018) 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur. Heart J., 39(2): 119–177. doi: 10.1093/eurheartj/ehx393.
- 4. Neumann F.J., Sousa-Uva M., Ahlsson A. et al. (2019) 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur. Heart J., 40(2): 87–165. doi: 10.1093/eurheartj/ehy394.
- 5. Rymer J.A., Wegermann Z.K., Wang T.Y. et al. (2024) Ventricular Arrhythmias After Primary Percutaneous Coronary Intervention for STEMI. JAMA Netw Open, 7(5): e2410288. doi: 10.1001/jamanetworkopen.2024.10288.
- 6. Wu X., Wu M., Huang H. et al. (2025) Incidence, predictors, and prognostic impact of reperfusion-related ventricular arrhythmias in STEMI patients undergoing primary percutaneous coronary intervention. BMC Cardiovasc. Disord., 25: 494. doi: 10.1186/s12872-025-04953-9.
- 7. Welt F.G.P., Batchelor W., Spears J.R. et al. (2024) Reperfusion Injury in Patients With Acute Myocardial Infarction: JACC Scientific Statement. J. Am. Coll. Cardiol., 83(22): 2196–2213. doi: 10.1016/j.jacc.2024.02.056.
- 8. Dhalla N.S., Ostadal P., Tappia P.S. (2025) Involvement of Oxidative Stress and Antioxidants in Modification of Cardiac Dysfunction Due to Ischemia-Reperfusion Injury. Antioxidants (Basel), 14(3): 340. doi: 10.3390/antiox14030340.
- 9. Shen M.J., Zipes D.P. (2014) Role of the autonomic nervous system in modulating cardiac arrhythmias. Circ. Res., 114(6): 1004–1021. doi: 10.1161/CIRCRESAHA.113.302549.
- 10. Benabou L., Vaseghi M. (2025) Cardiac Sympathetic Innervation and Ventricular Arrhythmias in Structural Heart Disease: Current Peripheral Neuromodulation Therapies and Emerging Therapeutic Targets. Arrhythm. Electrophysiol. Rev., 14: e34. doi: 10.15420/aer.2025.24.
- 11. Tsujita K., Shimomura H., Kawano H. et al. (2004) Effects of edaravone on reperfusion injury in patients with acute myocardial infarction. Am. J. Cardiol., 94(4): 481–484. doi: 10.1016/j.amjcard.2004.05.007.
- 12. Kikuchi K., Tancharoen S., Takeshige N. et al. (2013) The Efficacy of Edaravone (Radicut), a Free Radical Scavenger, for Cardiovascular Disease. Int. J. Mol. Sci., 14(7): 13909–13930. doi: 10.3390/ijms140713909.
- 13. Dhalla N.S., Elmoselhi A.B., Hata T., Makino N. (2000) Status of myocardial antioxidants in ischemia-reperfusion injury. Can. J. Cardiol., 16(2): 241–255.
- 14. Mužáková V., Kandár R., Vojtíšek P. et al. (2000) Selective antioxidant enzymes during ischemia/reperfusion in myocardial infarction. Physiol. Res., 49(3): 315–322.
- 15. Buffon A., Santini S.A., Ramazzotti V. et al. (2000) Large, sustained cardiac lipid peroxidation and reduced antioxidant capacity in the coronary circulation after brief episodes of myocardial ischemia. J. Am. Coll. Cardiol., 35(3): 633–639. doi: 10.1016/S0735-1097(99)00581-1.
- 16. Zhang X., Wei K.Y., Huang D. (2024) Effect of Propofol in the Cardiovascular System and its Related Mechanism Research Progress. Niger. J. Clin. Pract., 27(8): 938–944. doi: 10.4103/njcp.njcp_292_24.
|